A meta-analysis revealed that RAAS inhibitor monotherapy in patients with primary FSGS is significantly associated with a 32% reduction in proteinuria. Renin-angiotensin-aldosterone system (RAAS) ...
The renin–angiotensin–aldosterone system (RAAS) was initially thought to be fairly simple. However, this idea has been challenged following the development of RAAS blockers, including renin inhibitors ...
There is increasing evidence of a clinically relevant interplay between the renin–angiotensin–aldosterone system and calcium-regulatory systems. Classically, the former is considered a key regulator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback